Mitochondrial Research Group, Institute of Genetic Medicine, Newcastle University, Newcastle upon Tyne, UK.
Mitochondrion. 2011 Sep;11(5):686-92. doi: 10.1016/j.mito.2011.05.004. Epub 2011 May 27.
Mutations of mitochondrial DNA (mtDNA) cause a wide array of multisystem disorders, particularly affecting organs with high energy demands. Typically only a proportion of the total mtDNA content is mutated (heteroplasmy), and high percentage levels of mutant mtDNA are associated with a more severe clinical phenotype. MtDNA is inherited maternally and the heteroplasmy level in each one of the offspring is often very different to that found in the mother. The mitochondrial genetic bottleneck hypothesis was first proposed as the explanation for these observations over 20 years ago. Although the precise bottleneck mechanism is still hotly debated, the regulation of cellular mtDNA content is a key issue. Here we review current understanding of the factors regulating the amount of mtDNA within cells and discuss the relevance of these findings to our understanding of the inheritance of mtDNA heteroplasmy.
线粒体 DNA(mtDNA)突变导致广泛的多系统疾病,特别是影响高能量需求的器官。通常只有一部分 mtDNA 总量发生突变(异质性),而高水平的突变 mtDNA 与更严重的临床表型相关。mtDNA 是母系遗传的,每个后代的异质性水平与母亲的水平往往非常不同。线粒体遗传瓶颈假说最初被提出,作为对这些观察结果的解释,这一假说已经提出了 20 多年。尽管确切的瓶颈机制仍在激烈争论中,但细胞中线粒体 DNA 含量的调节是一个关键问题。在这里,我们回顾了目前对调节细胞内 mtDNA 数量的因素的理解,并讨论了这些发现对我们理解 mtDNA 异质性遗传的相关性。